top of page



An  Observational Drug Utilization Study of Stribild®in Adults with HIV- 1 Infection 


Protocol IDGS-EU-236 -0141

Protocol Version/Date:Original:17 April 2014

Amendment1: 20 October 2014

Amendment 2: 17 July 2015

Amendment 2.1: (Germany Only): 23 February2016


EU PAS Register NoENCEPP/SDPP/6524


Clinical IdentifierN/AActive substance

Elvitegravir, cobicistat, emtricitabine, tenofovir disoproxilStribild®150 mg/150 mg/200 mg/245 mg film-coated tablets

Medicinal Product


Stribild®Marketing Authorization Numbers

EU/1/13/830/001EU/1/13/830/002Procedure number


bottom of page